Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	-0.84%	63.47	$
CMSC	-0.13%	22.83	$
RYCEF	-0.65%	15.3	$
GSK	0.46%	54.47	$
VOD	-0.13%	15.49	$
AZN	-0.44%	186.68	$
RIO	-1.48%	98.49	$
NGG	0.25%	87.45	$
BP	0.82%	46.35	$
CMSD	-0.26%	23.2	$
RELX	-1.06%	36.01	$
JRI	-0.16%	12.81	$
BCC	-1.51%	82.61	$
BCE	-0.26%	23.5	$
BTI	1.97%	58.47	$

Featured

South Korean court hikes ex-president's sentence for obstructing justice

A South Korean appeals court increased the sentence of jailed former president Yoon Suk Yeol on Wednesday to seven years for obstructing justice, up from five years.

Sri Lanka government 'temporarily' takes over cricket board

Sri Lanka's government took control of the island's cricket board on Wednesday, saying it was a temporary measure designed to pave the way for "structural reforms".

Last news

Newsmax Draws Over 8 Million Viewers for Charlie Kirk Remembrance Service

BOCA RATON, FL / ACCESS Newswire / September 25, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today proudly announced that the Company's live coverage of the Charlie Kirk Remembrance Service from Phoenix delivered record-setting ratings, with over eight million Americans tuning in across its television platforms.

Alliance for Pharmacy Compounding Joins Pharmacy Podcast Network with New "Essential" Podcast

With podcasting reaching over 210M people in the United States today, building reliable content for Providers and business professionals in healthcare is a crucial communication's tool.

Kelly's Roast Beef Brings the Flavor to New Port Richey

Seventh Florida Location Opens September 26th, Fueled by Demand for Boston's Legendary Sandwiches and Seafood

Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts

MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI Facial Health Risk Estimator now includes early detection and monitoring of glaucoma and cataracts, two leading causes of vision loss globally.

Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globally

Arrive AI ($ARAI) Surpasses 1 Million Views on New to The Street TV Commercials

Joins global brands Goldman Sachs, KITON, FLOKI, Ford Motors, and IMG Academy in going viral across NTTS's YouTube and social media platforms

Plant-Powered Pups: New Study Shows Dramatic Environmental Gains From Plant-Based Dog Food in the UK

Key Results

MMJ's FDA Cannabis Softgel Capsule Could Be the Real Game Changer for Huntington's - Gene Therapy Sparks Hope

MMJ BioPharma Cultivation is completing its Cannabis DEA bulk manufacturing license process, a seven-year DEA battle that has delayed the company's ability to supply its FDA trials. Once approved, MMJ will begin GMP manufacturing of its softgel capsules for large scale clinical testing in Huntington's disease and Multiple Sclerosis.

ADM Toronto Keynotes Highlight Canada's Manufacturing Landscape

TORONTO, ON / ACCESS Newswire / September 25, 2025 / Advanced Design & Manufacturing (ADM) Toronto 2025, taking place October 21-23 at the Toronto Congress Centre, announces an impressive lineup of speakers addressing critical challenges and opportunities in Canada's manufacturing landscape. Currently, the sector completes 10% of the country's GDP, with over 1.7 million jobs across different verticals.

Organto Foods to Participate in Fruit Attraction Conference in Madrid, Spain

VANCOUVER, BC / ACCESS Newswire / September 25, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTC:OGOFF) ("Organto" or the "Company"), an integrated provider of branded, organic, and value-added organic and fairtrade fruit and vegetable products, is pleased to announce its participation in Fruit Attraction 2025 being held in Madrid, Spain and taking place from September 30th to October 2nd.

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025.

Wellgistics Health Announces Pricing of $5 Million Public Offering

TAMPA, FL / ACCESS Newswire / September 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the pricing of a public offering of 7,142,862 shares of common stock, together with warrants to purchase up to 7,142,862 shares of common stock at a combined public offering price of $0.70 per share and associated warrant. The warrants will have an exercise price of $0.70 per share, will be exercisable upon issuance and will expire five years thereafter. The closing of the offering is expected to occur on or about September 29, 2025, subject to the satisfaction of customary closing conditions.

Under-fire Brazil Senate scraps immunity bid

Brazil's Senate on Wednesday quashed a bid to expand criminal immunity for lawmakers after the proposal unleashed mass protests over the weekend.

Taiwan lake flood victims spend second night in shelters

Hundreds of flood victims in Taiwan prepared for a second night in shelters on Wednesday as rescuers searched for survivors after a barrier lake burst in torrential rains from Super Typhoon Ragasa.

S. Korea's ex-first lady goes on trial in corruption case

South Korea opened a criminal trial Wednesday for the wife of impeached former president Yoon Suk Yeol, marking the first time an ex-first lady has faced trial, after her husband was removed from office over a martial law bid.

Australian telco giant slapped with $66 million fine over 'appalling' conduct

Embattled Australian telco giant Optus was hit with a $66 million fine on Wednesday over "appalling" sales conduct as the firm grapples with fallout from a network outage linked to several deaths.

Massive sinkhole in Bangkok street forces evacuations

A portion of a busy road in Thailand's capital caved in early Wednesday, leaving a hole dozens of meters deep in front of a main hospital and forcing people nearby to evacuate.

Journal retracts study linking apple cider vinegar to weight loss

An influential study claiming that drinking a small amount of apple cider vinegar every day helps people lose weight was retracted on Wednesday after an investigation found it contained multiple errors.

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition

Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis results for crofelemer in the prespecified subgroup of patients with breast cancer from the OnTarget study that were reported at the Multinational Association of Supportive Care in Cancer 2025 Annual Meeting and the 2024 San Antonio Breast Cancer Symposium

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC Compliance Validator. Already live with eight healthcare organizations, the HCC Compliance Validator is a real-time tool that checks whether clinician-selected diagnoses are fully substantiated according to CMS documentation standards. The tool then identifies gaps in documentation for clinicians to address before notes are completed, helping clinicians prepare audit-ready notes.

Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital

In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer through trusted third-party financing partners, strengthening cash flow and supply chain resilience.

Medicus Pharma Ltd. To Present at Brookline Capital Markets

The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate CancerD-MNA and Teverelix collectively represent ~$8 billion in potential market opportunity

TruMerit and EnGen Partner to Equip Foreign-Educated Health Professionals With English Skills for Success in Work and Life

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 24, 2025 / TruMerit, a leader in global healthcare workforce development, is partnering with EnGen, a workforce-aligned English language learning solution, to support foreign-educated nurses and other healthcare professionals in building the language skills to succeed in English-speaking work environments and to flourish in their new communities.

CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth

CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering leader in innovative diagnostic and protective solutions, today announced a series of transformative advancements as it resumes full-scale operations. With groundbreaking progress on its flagship products, CS-Protect Hydrogel and MEDUSA, alongside a strategic capital raise and enhanced financial reporting, CSDX is poised to capture significant market share in the U.S. and international arenas.

Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection

MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in diabetes detection with its AI Facial Health Risk Estimator.

Who Is the Best Facial Feminization Surgeon in the U.S.?

Dr. Javad Sajan at Allure Esthetic is the best facial feminization surgeon in the U.S.

Congress Trying to Limit Marijuana Rescheduling, but DEA Can Still Act Now

Administrator Cole, you can fight illicit drugs and build a lawful, GMP-grade cannabinoid supply chain that shrinks the black market through science. Approve qualified marijuana manufacturers and research investigators now. Patients are waiting.

Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK

The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK populationThe facility marks a cornerstone of Moderna's ten-year strategic partnership with the UK Government, designed to strengthen health resilience and drive economic growth

William E. Parker Jr.'s I Thee Wed

Beyond the Manuscript - By Evrima Chicago

David Deaton: Thrillers That Make Global Conspiracy Personal

'Beyond the Manuscript' By the Editorial Team, Evrima Chicago

Kaye Allene Allen: Faith, Resilience, and Speaking to the Next Generation

Beyond the Manuscript Evrima Chicago

Christie Sikora: Worthy, For Such a Time as This

Beyond the Manuscript By the Editorial Team, Evrima Chicago

Arizona Tribune - Boulevard (English)